Head-to-head · Value Score
CoreAge Rx vs Belle Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Belle Health a 85. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBelle Health
#21 · Grade A- · Great Deal
Est. first month
$119/mo
Save ~91% vs brand-nameFDA warning letter. The FDA issued Belle Health LLC dba Belle a warning letter in February 2026. Check it on the FDA database.
Get this deal Full Belle Health review →The verdict
CoreAge Rx takes it on Value Score, 93 to 85 — an est. $99/mo first month, with no teaser step-up baked in. Belle Health isn't out of it: Someone who wants the price to stay put as the dose climbs, and who would rather see the pharmacy list and the regulatory record than be told to trust a brand.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Belle Health |
|---|---|---|
| Value Score | 93 (A+) | 85 (A-) |
| Est. first month | $99/mo | $119/mo |
| Save vs brand-name | ~89% | ~91% |
| Semaglutide | $99/mo | $119/mo |
| Tirzepatide | $149/mo | From $199/mo (all doses, 3-month plan, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Belle Health
Flat-rate compounded GLP-1s from a platform running since 2017 that names all five of its compounding pharmacies and also holds an FDA warning letter - an unusual combination of transparency and a live enforcement record.
Why it's a deal
- Names all five compounding pharmacy partners - Striker, Strive, OptioRx, Enovex and Braun PharmaCare. Most sellers at this price name none
- Flat-rate pricing that does not climb as you titrate up, so a dose increase does not arrive with a surcharge
- Dose increases, nutrition guidance and nurse support included at no extra cost, with a commitment to answer provider questions within 24 hours
- Two-day shipping included in the price
- Free weekly registered-dietitian sessions
- Operating since 2017 and LegitScript Certified, a longer track record than most of this field
- States on its own site that compounded medication is prepared by licensed pharmacies and is not evaluated by the FDA for safety or effectiveness
The fine print
- FDA issued a warning letter to Belle Health LLC dba Belle, dated February 2026. It is public in the FDA warning-letter database and linked from this review so you can read it yourself
- The tirzepatide price has been tied to a three-month commitment rather than a single month - check which plan you are agreeing to at checkout
- Compounded medication is not FDA-approved
- A five-pharmacy model means the formulation you receive may not come from the same place twice
- Publishes no cancellation terms on its home page, so ask before you start
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Belle Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.